HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lech Chrostek Selected Research

theasinensin A

11/2014Serum sialic acids levels according to the severity of liver cirrhosis.
3/2014Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.
1/2014Total and free serum sialic acid concentration in liver diseases.
1/2013Serum sialic acid as a marker of pancreatic cancers.
8/2010Lipid-bound sialic acid in alcoholics participates in increased level of total sialic acid.
11/2009[Usefulness of sialic acid determination to differentiation between alcohol abuse and alcoholic liver cirrhosis].
8/2009[The effect of chronic alcohol drinking on the total concentration of sialic acid and lipid-bound sialic acid].
11/2007Relationship between serum sialic acid and sialylated glycoproteins in alcoholics.
6/2007Serum free sialic acid as a marker of alcohol abuse.
8/2005[Diagnostic value of total and lipid-bound sialic acid in malignancies].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lech Chrostek Research Topics

Disease

21Alcoholism (Alcohol Abuse)
09/2013 - 06/2004
17Liver Diseases (Liver Disease)
09/2020 - 11/2009
14Fibrosis (Cirrhosis)
11/2021 - 04/2011
14Neoplasms (Cancer)
04/2020 - 11/2003
9Liver Cirrhosis (Hepatic Cirrhosis)
08/2021 - 11/2009
8Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2017 - 06/2008
6Rheumatoid Arthritis
06/2021 - 08/2012
5Inflammation (Inflammations)
03/2022 - 03/2014
4Hepatitis
03/2022 - 01/2016
4Rheumatic Diseases (Rheumatism)
06/2021 - 08/2012
4Neoplasm Metastasis (Metastasis)
03/2019 - 08/2005
4Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2017 - 11/2009
4Carcinogenesis
08/2008 - 06/2004
3Infections
08/2021 - 05/2004
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2021 - 03/2014
3Systemic Scleroderma (Systemic Sclerosis)
06/2021 - 03/2014
3Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2020 - 07/2017
3Chemical and Drug Induced Liver Injury
01/2017 - 04/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2016 - 08/2007
2Chronic Hepatitis (Chronic Active Hepatitis)
11/2021 - 12/2017
2Breast Neoplasms (Breast Cancer)
03/2019 - 01/2006
2Carcinoma (Carcinomatosis)
03/2019 - 07/2018
2Pathologic Processes
01/2017 - 12/2014
2Pancreatic Diseases (Pancreatic Disease)
09/2016 - 01/2011
2Alcoholic Fatty Liver
01/2015 - 09/2013
2Acute-Phase Reaction
03/2014 - 08/2012
2Malnutrition (Nutritional Deficiencies)
01/2013 - 04/2011
2Cardiovascular Diseases (Cardiovascular Disease)
04/2011 - 06/2008
2Iron Overload
03/2010 - 09/2008
2Stomach Neoplasms (Stomach Cancer)
08/2008 - 02/2007
1Chronic Pancreatitis
03/2022
1Pancreatitis
03/2022
1Hepatitis C
08/2021
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
09/2020
1Extrahepatic Cholestasis
09/2020
1Chronic Hepatitis B
01/2019
1Chronic Hepatitis C
01/2019
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2018
1Ovarian Epithelial Carcinoma
06/2017
1Ovarian Neoplasms (Ovarian Cancer)
06/2017

Drug/Important Bio-Agent (IBA)

18N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2019 - 06/2004
16Transferrin (beta 2 Transferrin)IBA
03/2022 - 01/2006
14Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2004
12Protein Isoforms (Isoforms)IBA
03/2022 - 01/2006
10LipidsIBA
01/2016 - 08/2005
10theasinensin AIBA
11/2014 - 08/2005
9Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2007
9Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
08/2008 - 07/2002
8Glycoproteins (Glycoprotein)IBA
11/2021 - 06/2007
8EnzymesIBA
07/2018 - 11/2003
8carbohydrate-deficient transferrinIBA
09/2016 - 01/2006
7IsoenzymesIBA
08/2008 - 07/2002
5Blood Proteins (Serum Proteins)IBA
11/2020 - 07/2011
5IronIBA
06/2019 - 03/2007
5CarbohydratesIBA
01/2019 - 01/2006
5Aldehyde DehydrogenaseIBA
08/2008 - 06/2004
5Ethanol (Ethyl Alcohol)IBA
08/2007 - 11/2003
4Polysaccharides (Glycans)IBA
11/2021 - 04/2011
4Hyaluronic Acid (Hyaluronan)IBA
06/2021 - 07/2014
4Tumor Biomarkers (Tumor Markers)IBA
04/2020 - 08/2005
4Lipoproteins (Lipoprotein)IBA
01/2016 - 06/2008
4AcetaldehydeIBA
09/2007 - 11/2003
3Indicators and Reagents (Reagents)IBA
06/2021 - 01/2006
3Galectin 3 (LGALS3)IBA
10/2020 - 12/2014
3Metalloproteases (Metalloproteinases)IBA
04/2020 - 04/2005
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2019 - 07/2017
3Tissue Inhibitor of Metalloproteinase-1IBA
03/2019 - 06/2017
3Apolipoproteins B (ApoB)IBA
01/2016 - 06/2008
3Triglycerides (Triacylglycerol)IBA
01/2016 - 06/2008
3Sialic AcidsIBA
11/2014 - 01/2006
3HomocysteineIBA
04/2011 - 01/2009
3Folic Acid (Vitamin M)FDA LinkGeneric
04/2011 - 01/2009
2Bile Acids and Salts (Bile Acids)IBA
03/2022 - 09/2020
2squamous cell carcinoma-related antigenIBA
04/2020 - 07/2018
2Macrophage Colony-Stimulating FactorIBA
04/2020 - 07/2018
2Biological ProductsIBA
12/2019 - 04/2011
2AntigensIBA
07/2018 - 01/2013
2disialotransferrinIBA
05/2016 - 01/2006
2ApolipoproteinsIBA
01/2016 - 06/2008
2HDL CholesterolIBA
01/2016 - 11/2014
2oxidized low density lipoproteinIBA
11/2014 - 06/2008
2CholesterolIBA
11/2014 - 06/2008
2VitaminsIBA
01/2013 - 04/2011
2Immunoglobulin G (IgG)IBA
08/2012 - 10/2007
2HaptoglobinsIBA
08/2012 - 10/2007
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2010 - 04/2005
2Alanine Transaminase (SGPT)IBA
06/2010 - 04/2005
1InterferonsIBA
08/2021
1CytokinesIBA
04/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2020
1Tissue Inhibitor of Metalloproteinase-2IBA
04/2020
1Rituximab (Mabthera)FDA Link
12/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2019
1OligosaccharidesIBA
01/2019
1ImmunosorbentsIBA
07/2018
1Procollagen Type IIBA
02/2018
1Interleukin-6 (Interleukin 6)IBA
02/2018
1Peptides (Polypeptides)IBA
05/2017
1Anti-Citrullinated Protein AntibodiesIBA
05/2017

Therapy/Procedure

2Therapeutics
08/2021 - 08/2005